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None of the proposed toxins or solute class of toxins has conclusively been shown to be responsible for the wide range of uremic symptoms. Nevertheless, chronic dialysis therapy has been successful in the treatment of end-stage renal patients, because it reverses several symptoms, at least partly. Therefore the question of objective criteria for adequate dialysis is still topical.
Although there is some consensus about basic criteria for adequate dialysis (5) (6) (7) (8) , such as maintaining fluid and electrolyte balance, adequacy is difficult to define as long as there is no information about the identity of the solutes that should be removed preferentially. Moreover, dialysis tuned to the needs of individual patients requires knowledge of both the identity of the "toxins" and the structure of the dialyzed patients' population relative to these toxins.
Some time ago, we suggested a proffling approach with use of modern analytical techniques and multivariate analysis to study accumulation of uremic solutes (9,10). Twentytwo characteristic uremic solutes in sera of dialyzed and non-dialyzed uremic patients were subjected to principal component analysis, in order to explore interdependencies between these concentrations and their distribution in different patients. These ultraviolet-absorbing and (or) fluorescent solutes were analyzed by gradient-elution high-performance liquid chromatography (HPLC) as described previously (10, 11).
Although multivariate techniques have been used by Lowrie et al. (7) , to our knowledge this is the first time that a multivariate study in the present form has been reported.
Materials and Methods

Patients and Sera
Pre-dialysis blood samples were collected from 33 uremic dialyzed patients and from 32 non-dialyzed patients. Dialyzed patients were treated by single-needle hemodialysis, with use of different types of dialyzers. Serum samples were ultrafiltered with "Centrifree" ultrafiltration units (Amicon, Danvers, MA) to remove serum proteins. The ifitrate was diluted with an equal volume of a solution of internal standard, naphthalene sulfonic acid (37 mg/L), and subsequently analyzed by HPLC.
Procedures
HPLC. This was performed as described previously (10, 11). A column of "Ultrasphere Octyl" (C8-modifled silica), 4.6 mm (i.d.) x 25 cm, with 5-pm particles, was used in conjunction with an Ultrasphere Octyl guard column, 2 mm (i.d.) x 3 cm, with 10-p.m particles.
The solvent gradient was linear from 100% aqueous ammomum formate buffer (50 mmol/L, pH 4) to 60% methanolJ4O% buffer within 45 miii. The flow rate was 1 mL/min. The separation column and the solvent were kept at 25#{176}C by means of a thermostated bath and column water jacket. The chromatograph consisted of a Model 421 controller, two Model 100A double-piston pumps, a Model 160 fixedwavelength ultraviolet detector (wavelength 254 nni, range 0.05 A full scale) and a Model 500 autosanipler (all from Beckman Instruments, Fullerton, CA). Additionally, we used fluorescence detection at 280 n.m (excitation) and 340 nm (emission), in a Model RF530 double-monochromator fluorescence detector (Shimadzu, Tokyo, Japan).
Data acquisition and statistics. For chromatographic data acquisition and handling we used a Model 761S data interface and Model 2600 chromatography software (both from Nelson Analytical, Cupertino, CA). Data were read in SAS data ifies and analyzed with SAS statistical software (SAS Institute Inc., Cary, NC). We used the SAS-procedures FACTOR and cona for principal component analysis and correlation analysis, respectively (12). Total ultraviolet absorbance at 254 n.m and total fluorescence emission (at 280 n.m excitation and 340 n.m emission) were evaluated by determining total peak areas under the ultraviolet and fluorescence traces of the HPLC chromatograms.
Principal component analysis. In principal component (PC) analysis a set of measured variables may be transformed into a smaller set of non-correlated variates that describe a large proportion of the variation in the original variable set. In this way a dimension reduction of the original data is obtained.
The variates or principal components are linear combinations of the measured variables, according to:
where W are variable weighting coefficients and x3 are the measured variable scores (j = 1,2,. . .p; p variables, and i = 1,2,. . . k; k components, where k p). The PCs are extracted so that PCi is the linear combination describing the largest amount of variation in the data, and PC2, PC3, etc. comprise linear combinations that describe subsequent largest amounts of variation in such a way that PCi, PC2, etc. are all non-correlated. This is done by calculating the subsequent eigenvalues A and corresponding eigenvectors y of the correlation matrix R. The eigenvectors are the respective weighting coefficient vectors (W) as encountered in the equation given above. Principal components are extracted under the constraints of = 0 and yj1' = 1, where y, and y2 denote subsequent eigenvectors.
The maximum number of extracted components is equal to the number of variables. Total variance of the standardized data is the sum of the diagonal elements of the correlation matrix, which amounts to p, the number of variables.
The variance explained by individual principal components equals the corresponding eigenvalue divided by the total variance: X11p. There are several criteria for the number of components to retain. In the present study, we used a discontinuity in a plot of principal component eigenvalues as a function of extraction order. By using a correlation matrix rather than a variance-covariance matrix, data were standardized to account for large differences in variance of variables expressed in different scales and units. After extraction of PCs, orthogonal rotation of the PC pattern was performed with the varimax method. This consists of a maximization of the variance in the columns of the PC matrix, which results in values for the column elements as near as possible to 0, -1, or 1.
We used the FACTOR procedure from SAS statistical software (12). Figure 1 shows representative chromatograms of ultrafiltered sera. These proffles will be discussed below. Besides the 20 compounds measured with HPLC, phosphate and urea were quantified conventionally.
Results
A correlation matrix of the solute concentrations was factored in a principal component analysis, to obtain a smaller number of mutually independent "summary variables," and to allow us to visualize correlations and interdependencies between the concentrations of the respective
solutes.
Dialyzed uremic patients. After judgment of a plot ( Figure  2a ) of eigenvalues vs PC extraction number, three principal components were retained from the data of the hemodialyzed group. These three components describe 49% of total variance in the scaled data (PC 1, 22%; PC2, 15%; PC3, 12%). After orthogonal rotation (varimax), a factor pattern was obtained, of which a projection on the PC1-PC2 plane is shown in Figure 3 . Table i lists variables and their loadings on the principal components. Four "clusters" of solutes may be distinguished in Figure 3 and Table 1 .
Group A has high loadings on exclusively PCi. Group B is closely related to PC2, group C has very high loadings on PC3, and group D seems to be related to PC2 and less so to PCi.
Here it may be noted that PC2 summarizes a number of solutes that hitherto have been used as clinical markers of uremia: urea, uric acid, creatinine, and phosphate.
On the other hand, PCi comprises a number of aromatic and indolic compounds, such as p-hydroxyhippuric acid, hippuric acid, tryptophan, and the unidentified fluorescent solutes UKF1, UKF4, and UKF7A; and it correlates significantly with residual renal ftmction in these dialyzed patients. Furthermore, PCi correlates significantly with the more-general measures of accumulation, total ultraviolet absorbance and total fluorescence emission, that are described in the Methods section. Table 2 gives a correlation matrix for the PCi, PC2, and PC3 scores, residual renal function, total ultraviolet absorbance, and total fluorescence.
Non-dialyzed patients. From the plot of eigenvalues in Figure 2b , we decided that only one PC should be retained after factoring the correlation matrix of the data of nondialyzed (preterminal) uremic patients. This single principal component describes 49% of the variance in the scaled data. Loadings of the original solute concentrations on this PC are given in Table 3 . The PC scores correlate significantly with residual renal function, total ultraviolet absorbance, and total fluorescence emission, as was also observed for PCi in the group of dialyzed patients. Table 4 gives a correlation matrix.
Structure of the dialyzed-patients group. From the original data and the weights of the variables on the principal components, we calculated standardized patient scores on the "summary variables" PCi, PC2, and PC3.
The data for PCi and PC2 are given in the bivariate scatter plot in Figure 4 . We saw no instance of a high score for one PC and a low score for the other.
Accumulation as a function of residual creatinine clearance. Concentrations of the 22 compounds in the combined dialyzed and non-dialyzed patient groups were plotted vs residual creatinine clearance. Mainly two types of curves were obtained, one in which there was a significant concentration increase when residual creatinine clearance was 60 mllmin, and one in which this occurred at only 20 mL/min (see also Table 5 ). The first type was found for urea, uric acid, creatinine, pseudouridine, UK5, and UKF3, all (mainly) belonging to PC2. The second type was observed with phydroxyhippuric acid, hippuric acid, UKF1, UKF4, and UKF7A, belonging to PCi; phosphate (PC2); and UKF7, UKF8, and 3-indoleacetic acid from PC3. Figure 5a shows the curves for urea, creatinine, and p-hydroxyhippuric acid. 
number
The region between residual creatinine clearance = 5 roll mm and 0 mlimin (i.e., the dialyzed patients) is expanded in Figure 5b .
Discussion
In the present andy we have examined the interdependendes of the concentrations of 22 solutes in uremic sera. They include urea, phosphate, creatinine, pseudouridine, uric acid, hypoxanthine, p-hydroxyhippuric acid, hippuric acid, tyrosine, indoxylsulfate, tryptophan, and 3-indoleacetic acid, and some unknown ultraviolet-absorbing and fluorescent compounds. The unknown compounds encountered in the HPLC chromatograms could be quantified from the peak height. The solutes originate from different metabolic processes. Urea is an end product of protein catabolism.
Phosphate is related to protein intake or, more generally, to diet (possibly as phospholipids) and as such is correlated with urea. Pseudouridine is a product of specific tRNAturnover. Uric acid and hypoxanthine are more-general products of nucleic acid metabolism. Creatinine is the product of phosphocreatine degradation. Hippuric acid mainly originates from the diet, being formed after conjugation of glycine to benzoic acid; the latter is widely used as a food preservative, occurs naturally in different foodstuffs, and is a product of phenylalanine metabolism. p-Hydroxyhippuric acid may be an endogenous compound related to tyrosine metabolism. The first principal component ("summary variable") for the group of dialyzed patients appears to be formed by aromatic and indolic compounds, most of which show significant individual correlation with residual renal function ( Table 5 ). This has been reported earlier for the ultravioletabsorbing compounds (13). A number of them exhibit protein binding (Table 5 
) (11).
Aromatic compounds exert various toxic effects, especially inhibition of cerebral enzyme action (14) and inhibit ion transport across cell membranes in various tissues (15-19) . Although some of the fluorescent PCi solutes are not yet identified, they may also be indolic or aromatic compounds, as judged from their fluorescence emission at the wavelength combination we used.
The second PC seems to be related to a number of compounds whose concentrations are not directly correlated with residual renal function in terms of residual creatinine clearance, and that have been used as uremic markers in the past, among which are phosphate and the nitrogenous FIg .5. (a, upper panels) Plots ofserum concentrationsofurea,creatinine,and phydroxyhlppurlc acid as a functionof residualcreatinineclearance Dataforbothnondalyzed(resIdual creatinlne clearance, >5 mLJmln) anddialyzed(residual creatinlne clearance. <5 mLln) we shown (b, biter panels) Plots similar to those of a, but for dialyzed patients only acid, p-hydroxyhippuric acid, UKF1, UKF4, and IJKF7A, edly, hippurate). As the concentrations of the latter solutes all belonging to PCi. These substances probably are mostly in the serum of dialyzed patients were reported (11) to be excreted by renal tubular secretion and follow the "organic significantly smaller (p-hydroxyhippuric acid range 4-63 acid secretory meotheniem" (25) . On the other hand, concenpznol/L, hippuric acid range 36-894 zmol/L, both for the trations in serum of a number of compounds associated with non-protein-bound fraction) than this limit, they will still be PC2 had increased significantly at residual creatinine clearexcreted mainly by tubular secretion in intact nephrons of ances of 60 3JJmin: urea, creatinine, pseudouridine, UK5, the residual renal mass in dialyzed uremic patients. and uric acid. This suggests excretion, at least predominantIn different studies the inhibitory effect of uremic serum ly, by filtration. In normal functioning nephrons, the contrion p-aminohippurate and o-iodohippurate transport in isobution of tubular secretion to total excretion of p-aminohiplated tubules and kidney slices has been reported (16,17, purate is more than sixfold that of glomerular filtration, as 27). Inhibition of ion transport across cell membranes in long as the concentration in serum is <1000-1500 imol/L. other tissues has also been reported (15,18). It was proposed Above this value the secretory mechanism becomes saturatthat the inhibition of tubular flmction was exerted by high ed (25) . It has been shown by Smith et al. (26) that pconcentrations of hippurates and indoleacetic acids, and not hydroxyhippuric acid and p-aminohippurate have identical by urea, uric acid, and creatinine (16) . Unlike the organic renal clearances inhumane. Thereforetheabove-mentioned acids, these latter solutes are associated with the second limit of 1000-1500 pmol/L for p-aminohippurate will conprincipal component (PC2) in the present study. ceivably be valid also for p-hydroxyhippurate (and, supposThere is evidence for the "toxicity" of solutes from both 'PC number with highestcorrelationfirst. PCi and PC2-urea and phosphate representing protein toxicity, bone disease, and parathyrin toxicity, respectively, and the organic acids as inhibitors of ion transport in tissues and of cerebral enzymes (14). Therefore, dialysis should be designed to remove compounds from both groups, and it is important to know what are the relative PC scores ("summary concentrations") for the groups of solutes in the individual dialyzed patients.
The structure of the patient group with respect to the uncorrelated principal components is shown in Figure 4 . An adequate amount of dialysis in one patient that brings down the level of 0PC2" to within acceptable limits may not suffice to attain acceptable levels of "PCi," because the relative scores on the components may be very different among patients (e.g., patients i and i5 in Figure 4) . As an example we consider patient 1. When this patient is dialyzed for urea (associated to PC2) according to patient kinetic modelling results, a small amount of dialysis may be enough, because the score for PC2 is only of intermediate magnitude. However, this may not suffice to decrease the concentrations in serum of solutes associated to PCi, which are relatively high in this patient's serum, to acceptable values.
PC analysis on the data of the non-dialyzed patient group appears to result in one single component (PCi). This single PC contains almost all those compounds that are associated with three independent principal components in the data for the dialyzed patients. Compounds such as p-hydroxyhippuric acid and hippuric acid, described by PCi in the dialyzed group, only appeared in the blood of non-dialyzed patients when residual renal function decreased below 20 mL/min. This accords with reported data (19) and may be part of the answer to the question of why additional principal components appear in dioiyzed patients (residual renal function of 0 to 5 mLfmin).
Different groups of uremia-accumulated compounds with which the concentrations in serum were associated could be distinguished in the dialyzed patients' sera. Choosing a single marker, such as urea, to describe uremic solute retention seems only justified in the case of non-dialyzed patients whose residual renal function exceeds 20 mllmin. In this group the concentrations of almost all accumulated solutes are inter-correlated and also with residual renal function.
In the group of dialyzed patients, relative scores for the "summary concentrations" differ between patients. Sargent (20) , who advocates the otherwise rational approach of urea kinetic modelling, stated that". . . the goal of modelling therapy should not be overly ambitious in its attempt to create an all-indusive description of uremia."
The present study shows that concentrations of a group of "organic acid-like" substances vary relatively independent from those of another group, including classical markers such as urea, creatinine, and uric acid, and that the relative "concentrations" of these groups differ between patients. Dialyzed patients with negligible residual creatinine clearance generally have a higher ratio of PCi to PC2 than do patients with some remaining renal function or, to put it loosely, have relatively high concentrations of "organic acid" as compared with urea and creatinine. There was a significant negative correlation of the PC1/PC2 ratio with residual creatinine clearance (r = -0.45, P <0.Oi). This suggests that adequate dialysis should imply distinguishing between accumulated solute groups that differ with respect to the mechanism of excretion in intact nephrons. In its consequences this would be a different approach to accounting for remaining renal function, as is done in the approach of a "Dialysis Index" (28) , which was proposed to model the socalled middle molecules. In that approach, a hypothetical middle molecule of Mr i300 was used, the removal of which would benefit from any residual renal glomerular ifitration (29) , because the glomerulus filters these substances as easily as low-molecular-mass solutes, which is not true for the dialyzer membrane. Contrary to the hypothetical nonmeasurable "middle molecule" (9, 30), now one of the analytically well-defined organic acids, or more specifically hippurates, may be used as a measure of accumulation of "organic-acid-like" substances. It is an important observation that any residual renal function contributes to the well-being of dialyzed patients, whatever the precise explanation (31). Whether this is a consequence of accumulation of tubularly secreted organic acids in patients with negligible renal function remciins to be established.
In conclusion, it seems worthwhile to introduce a marker for the accumulation of "organic-acid-like" compounds in addition to urea (34) . This could contribute to the goal of "adequate dialysis"
in the light of the proven toxicity of these substances. p-Hydroxyhippuric acid or hippuric acid might prove to be suitable. A choice should be based on considerations of protein binding, measurability, single or multipool kinetica, variation with diet, and (mode of) endogenous generation. In this perspective, the early work of Smith et al. (26) and others regains topicality.
